Department of Nuclear Medicine, University Hospital, LMU Munich, Munich, Germany; Ahmanson Translational Theranostics Division, David Geffen School of Medicine, University of California Los Angeles (UCLA), Los Angeles, USA.
Department of Radiation Oncology, University Hospital, LMU Munich, Munich, Germany.
Radiother Oncol. 2024 Sep;198:110386. doi: 10.1016/j.radonc.2024.110386. Epub 2024 Jun 14.
PET is increasingly used for target volume definition in the radiotherapy of glioblastoma, as endorsed by the 2023 ESTRO-EANO guidelines. In view of its growing adoption into clinical practice and upcoming PET-based multi-center trials, this paper aims to assist in overcoming common pitfalls of FET PET-based target delineation in glioblastoma.
正电子发射断层扫描(PET)越来越多地用于胶质母细胞瘤的放射治疗靶区定义,这得到了 2023 年欧洲放射肿瘤学会-欧洲神经肿瘤学会(ESTRO-EANO)指南的认可。鉴于其在临床实践中的应用日益广泛,以及即将进行的基于 PET 的多中心试验,本文旨在帮助克服基于 FET PET 进行胶质母细胞瘤靶区勾画的常见陷阱。